Acquisition by Borgman Anne Elizabeth of 25000 shares of Curis subject to Rule 16b-3

CRIS Stock  USD 4.03  0.08  1.95%   
Slightly above 67% of Curis' investor base is looking to short. The analysis of the overall investor sentiment regarding Curis Inc suggests that many traders are alarmed. Curis' investing sentiment can be driven by a variety of factors including economic data, Curis' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Curis Inc Director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Curis insider trading alert for acquisition of non qualified stock option by Borgman Anne Elizabeth, Director, on 11th of October 2024. This event was filed by Curis Inc with SEC on 2022-10-12. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Curis' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Curis' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Curis Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Curis can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Curis Fundamental Analysis

We analyze Curis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Target Price

Target Price Comparative Analysis

Curis is currently under evaluation in target price category among its peers.

Curis Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Curis stock to make a market-neutral strategy. Peer analysis of Curis could also be used in its relative valuation, which is a method of valuing Curis by comparing valuation metrics with similar companies.

Peers

Curis Related Equities

LPTXLeap Therapeutics   11.32   
0%
100.0%
CRVSCorvus Pharmaceuticals   7.45   
0%
65.0%
ALRNAileron Therapeutics   4.07   
0%
35.0%
ADAPAdaptimmune Therapeutics   3.07   
0%
27.0%
XFORX4 Pharmaceuticals   2.94   
0%
25.0%
TERNTerns Pharmaceuticals   1.55   
0%
13.0%
PIRSPieris Pharmaceuticals   1.37   
0%
12.0%
DAWNDay One   0.89   
0%
7.0%
MREOMereo BioPharma   0.59   
0%
5.0%
INZYInozyme Pharma   0.38   
0%
3.0%
ARTLArtelo Biosciences   0.90   
7.0%
0%
PDSBPDS Biotechnology   2.76   
24.0%
0%
APTOAptose Biosciences   2.78   
24.0%
0%
AFMDAffimed NV   4.18   
36.0%
0%

Additional Tools for Curis Stock Analysis

When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.